JPWO2020051151A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2020051151A5
JPWO2020051151A5 JP2021536672A JP2021536672A JPWO2020051151A5 JP WO2020051151 A5 JPWO2020051151 A5 JP WO2020051151A5 JP 2021536672 A JP2021536672 A JP 2021536672A JP 2021536672 A JP2021536672 A JP 2021536672A JP WO2020051151 A5 JPWO2020051151 A5 JP WO2020051151A5
Authority
JP
Japan
Prior art keywords
alkyl
alkynyl
alkenyl
pharmaceutical composition
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021536672A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021536504A (ja
JP2021536504A5 (https=
JP7466544B2 (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/049368 external-priority patent/WO2020051151A1/en
Publication of JP2021536504A publication Critical patent/JP2021536504A/ja
Publication of JPWO2020051151A5 publication Critical patent/JPWO2020051151A5/ja
Publication of JP2021536504A5 publication Critical patent/JP2021536504A5/ja
Priority to JP2024059527A priority Critical patent/JP2024084794A/ja
Application granted granted Critical
Publication of JP7466544B2 publication Critical patent/JP7466544B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021536672A 2018-09-04 2019-09-03 テトラサイクリン化合物を使用してマイコバクテリア感染症を処置する方法 Active JP7466544B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024059527A JP2024084794A (ja) 2018-09-04 2024-04-02 テトラサイクリン化合物を使用してマイコバクテリア感染症を処置する方法

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US201862726738P 2018-09-04 2018-09-04
US62/726,738 2018-09-04
US201862731410P 2018-09-14 2018-09-14
US62/731,410 2018-09-14
US201862746039P 2018-10-16 2018-10-16
US62/746,039 2018-10-16
US201862760131P 2018-11-13 2018-11-13
US62/760,131 2018-11-13
PCT/US2019/049368 WO2020051151A1 (en) 2018-09-04 2019-09-03 Methods of treating mycobacterial infections using tetracycline compounds

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024059527A Division JP2024084794A (ja) 2018-09-04 2024-04-02 テトラサイクリン化合物を使用してマイコバクテリア感染症を処置する方法

Publications (4)

Publication Number Publication Date
JP2021536504A JP2021536504A (ja) 2021-12-27
JPWO2020051151A5 true JPWO2020051151A5 (https=) 2022-09-06
JP2021536504A5 JP2021536504A5 (https=) 2022-09-06
JP7466544B2 JP7466544B2 (ja) 2024-04-12

Family

ID=69722600

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021536672A Active JP7466544B2 (ja) 2018-09-04 2019-09-03 テトラサイクリン化合物を使用してマイコバクテリア感染症を処置する方法
JP2024059527A Pending JP2024084794A (ja) 2018-09-04 2024-04-02 テトラサイクリン化合物を使用してマイコバクテリア感染症を処置する方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024059527A Pending JP2024084794A (ja) 2018-09-04 2024-04-02 テトラサイクリン化合物を使用してマイコバクテリア感染症を処置する方法

Country Status (13)

Country Link
US (2) US12161655B2 (https=)
EP (1) EP3846805A4 (https=)
JP (2) JP7466544B2 (https=)
KR (2) KR20260036400A (https=)
CN (1) CN113164456A (https=)
AU (2) AU2019335203B2 (https=)
BR (1) BR112021004057A2 (https=)
CA (1) CA3111447A1 (https=)
MA (1) MA53564A (https=)
MX (2) MX2021002503A (https=)
PH (1) PH12021550452A1 (https=)
SG (1) SG11202102149SA (https=)
WO (1) WO2020051151A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7840880B2 (ja) * 2020-06-11 2026-04-06 パラテック ファーマシューティカルズ,インコーポレイテッド オマダサイクリンの結晶形態、その合成方法及びその使用方法
TW202237116A (zh) * 2020-12-02 2022-10-01 日商塩野義製藥股份有限公司 以組合細胞色素bc1抑制劑與克拉黴素或阿奇黴素為特徵之用於治療分枝桿菌感染之藥物
JP2024511419A (ja) * 2021-03-24 2024-03-13 インスメッド インコーポレイテッド 非結核性抗酸菌肺疾患を治療するための併用療法
WO2025221846A1 (en) * 2024-04-18 2025-10-23 St. Jude Children's Research Hospital, Inc. Compositions and methods for treating non-tuberculosis mycobacteria infections

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA009175B1 (ru) 2000-07-07 2007-12-28 Трастис Оф Тафтс Коллидж Замещенные соединения миноциклина, фармацевтическая композиция и способ лечения чувствительного к тетрациклину состояния млекопитающего
US7553828B2 (en) 2001-03-13 2009-06-30 Paratek Pharmaceuticals, Inc. 9-aminomethyl substituted minocycline compounds
US20060194773A1 (en) 2001-07-13 2006-08-31 Paratek Pharmaceuticals, Inc. Tetracyline compounds having target therapeutic activities
EP2311451A1 (en) 2002-03-08 2011-04-20 Paratek Pharmaceuticals, Inc. Amino-methyl substituted tetracycline compounds
PT2271348T (pt) * 2008-03-28 2018-04-16 Paratek Pharm Innc Formulação de comprimido oral de composto de tetraciclina
TWI680117B (zh) 2008-05-19 2019-12-21 派洛泰克藥物股份有限公司 四環素化合物之甲苯磺酸鹽及同素異形體
KR101732084B1 (ko) 2011-07-26 2017-05-02 케이비피 바이오사이언시즈 씨오., 엘티디. 9-아미노메틸 치환된 테트라사이클린 화합물
JP2015527403A (ja) 2012-09-11 2015-09-17 メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. Hivプロテアーゼ阻害剤
CA3018872A1 (en) * 2016-03-24 2017-09-28 Paratek Pharmaceuticals, Inc. Methods of treating a bacterial infection in a subject at risk of developing c. difficile infection
JP2019514952A (ja) * 2016-05-02 2019-06-06 パラテック ファーマシューティカルズ,インコーポレイテッド 9−アミノメチルミノサイクリン化合物及び尿路感染症(uti)の処置におけるその使用方法
TW202206081A (zh) * 2016-08-03 2022-02-16 美商派瑞泰Spv2有限公司 9—胺甲基米諾四環素化合物及其用途
GB201615693D0 (en) * 2016-09-15 2016-11-02 Combinatorx Infection Ltd Combinations

Similar Documents

Publication Publication Date Title
JP2021536504A5 (https=)
US10653619B2 (en) Drug depots for treatment of pain and inflammation
US9265733B2 (en) Drug depots having different release profiles for reducing, preventing or treating pain and inflammation
US20250049817A1 (en) Jak inhibitor with a vitamin d analog for treatment of skin diseases
US20110027331A1 (en) An implantable drug depot having a reversible phase transition material for treatment of pain and/or inflammation
JP2019522039A5 (https=)
US20090263489A1 (en) Analgesic and anti-inflammatory compositions and methods for reducing, preventing or treating pain and inflammation
US6552083B1 (en) Agents inhibiting chronic rejection reactions after organ transplantation
KR101307650B1 (ko) 구역에 대한 경피 방법 및 패치
US5922701A (en) Method for enhancing or accelerating re-epithelialization or re-endothelialization of a tissue
AU2025234215A1 (en) Methods of treating mycobacterial infections using tetracycline compounds
JP2017535546A5 (https=)
JPWO2020051151A5 (https=)
JP2020505322A (ja) 局所用デトミジン製剤
US4005207A (en) Synergistic therapeutic composition for the treatment of mycobacterioses
US9849126B2 (en) Sterile otic formulations
US20100158990A1 (en) Transdermal method and patch for corticosteroid administration
US12599609B2 (en) Methods of treating fuchs endothelial corneal dystrophy after descemetorhexis
Aperis et al. Corynebacterium minutissimum endocarditis: a case report and review
US12576049B1 (en) Onychomycosis treatment methods
CA2327326A1 (en) Topical administration of oxazolidinones for transdermal delivery
RU2831120C2 (ru) Способы лечения микобактериальных инфекций с применением тетрациклиновых соединений
RU2021106524A (ru) Способы лечения микобактериальных инфекций с применением тетрациклиновых соединений
EP4422616A1 (en) Human efficacious dose and dosage schedule of spr720
WO2017147003A1 (en) Novel macrocyclic antibiotics and uses thereof